Skip to main content

Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About
Trending Topics
    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Entertainment & Media
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor, Employment, and Benefits
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations
    Industries

    View All

    • Aviation
    • Cannabis
    • Consumer
    • Energy
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Nonprofit Organizations
    • Real Estate
    • Sports & Stadiums
    • Technology
    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Environmental, Social, and Governance (ESG)

      We help clients create positive return on investments in people, products, and the planet.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    • Women in Dealmaking

      We provide strategic counsel on complex corporate transactions and unite dynamic women in the dealmaking arena.

    1. Home
    2. Insights
    3. Alerts
    4. 美国食品药品管理局禁止奶瓶和儿童杯使用双酚A——其注意力现可能转向其它产品

      Alerts

    Alert / Asia Pacific Alert

    美国食品药品管理局禁止奶瓶和儿童杯使用双酚A——其注意力现可能转向其它产品

    July 25, 2012

    LinkedInX (Twitter)EmailCopy URL
    2012年7月25日,星期二,美国食品药品管理局最终颁布了关于禁止在奶瓶和儿童用饮料杯中使用化学添加剂双酚A(BPA)的条例。该条例是对美国化学委员会一份公告的回应,在该公告中,美国化学委员会认为:在美国,双酚A不再使用于制造此类产品而且将来也不会被用于制造此类商品。

    2012年7月17日,星期二,美国食品药品管理局最终颁布了关于禁止在奶瓶和儿童用饮料杯中使用化学添加剂双酚A(BPA)的条例。该条例是对美国化学委员会一份公告的回应,在该公告中,美国化学委员会认为:在美国,双酚A不再使用于制造此类产品而且将来也不会被用于制造此类商品。美国本土以外的制造商应当了解到该新条例将通过由美国食品药品管理局和美国海关的代理机构在入境口岸对进口产品进行检测和测试的方式实施。

    2012年3月,美国食品药品管理局否决了一份来自某代表消费者利益的组织的有关禁止双酚A在所有食品和饮料的包装中使用的请求函。然而美国国会仍在考虑通过立法来有效地扭转美国食品药品管理局的决定并禁止双酚A在所有罐头食品容器和塑料饮料瓶中的使用。同时,国会的成员还请求美国食品药品管理局颁布一项条例以禁止双酚A在罐头食品的内衬、小的可再利用的食品和饮料容器以及儿童食品的包装中的使用。美国许多州已经禁止或者正在考虑禁止双酚A在其它物品中的使用,包括玩具。

    双酚A在食品和非食品产品中的未来部分取决于对相关科学证据的评估。尼克松•皮博迪律师事务所最近发表了对该类证据的评论。我们发现,总的来说,禁止或者限制双酚A的支持者所依赖的研究缺乏科学可靠的研究来说明没有不良的健康影响。例如,对双酚A证据权重分析研究表明,符合严格科学标准的对接触低剂量双酚A的影响的研究倾向于显示接触低剂量双酚A没有不良影响。相反,表明此种接触存在潜在的不良影响的研究数量少,科学可靠性也小。此外,可靠的科学证据表明与之接触的实验室动物所受的不良影响不会轻易地转移到人类身上。最后,还没有充分的证据表明人体含有少量的双酚A与实际的不良健康影响有联系,并且对普通人群的研究表明,双酚A水平和不良影响的各种征象之间的关系不大。

    有关双酚A和其影响的争议可能会转战到法庭。尽管个人控告因产品受到伤害并要求金钱赔偿的案件在法庭上胜诉率不高,但是代表这些个人起诉制造商的律师们还是继续呼吁客户就与双酚A有关的疾病或伤害进行索赔。将来,美国食品药品管理局将会继续因为双酚A在食品和饮料包装上的使用而受到来自代表个人消费者的各个团体和政客的压力。

    The foregoing has been prepared for the general information of clients and friends of the firm. It is not meant to provide legal advice with respect to any specific matter and should not be acted upon without professional counsel. If you have any questions or require any further information regarding these or other related matters, please contact your regular Nixon Peabody LLP representative. This material may be considered advertising under certain rules of professional conduct.

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • Cookie Preferences
    • Privacy Policy
    • Terms of Use
    • Accessibility Statement
    • Statement of Client Rights
    • Purchase Order Terms & Conditions
    • Nixon Peabody International LLC
    • PAL
    © 2025 Nixon Peabody. All rights reserved